Chapter 1. VACCINES FOR HUMAN MEDICINE MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. VACCINES FOR HUMAN MEDICINE MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. VACCINES FOR HUMAN MEDICINE MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. VACCINES FOR HUMAN MEDICINE MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. VACCINES FOR HUMAN MEDICINE MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. VACCINES FOR HUMAN MEDICINE MARKET – By Technology Type

6.1. Inactivated Vaccines

6.2. Toxoid Vaccines

6.3. Recombinant & Conjugate Vaccines

6.4. Live Attenuated Vaccines

6.5. Others

Chapter 7. VACCINES FOR HUMAN MEDICINE MARKET – By Indication

7.1.  Rotavirus

7.2. Varicella

7.3. Measles, Mumps, & Rubella

7.4. Diphtheria, Pertussis, & Tetanus (DTP)

7.5. Polio

7.6. Hepatitis

7.7. Pneumococcal Disease

7.8. Influenza

7.9. Human Papilloma Virus

7.10. Meningococcal Disease

7.11. Others

Chapter 8. VACCINES FOR HUMAN MEDICINE MARKET – By End-User

8.1. Travellers

8.2. Paediatric

8.3. Adults

Chapter 9. VACCINES FOR HUMAN MEDICINE MARKET – By Region

9.1. North America

9.2. Europe

9.3.The Asia Pacific

9.4.Latin America

9.5. Middle-East and Africa

Chapter 10. VACCINES FOR HUMAN MEDICINE MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company  8

10.9. Company 9

10.10. Company 10

Download Sample